JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES.

摘要

This invention relates to JAK1 selective inhibitors, particularly pyrrolo[2,3-d]pyrimidine and pyrrolo[2,3-b]pyridine derivatives, and their use in treating myelodysplastic syndromes (MDS).